These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 17849811)

  • 41. Cardiovascular health and the menopause: the gynecologist as the patients' interface.
    Arias RD
    Climacteric; 2006 Sep; 9 Suppl 1():6-12. PubMed ID: 16899438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controversies regarding hormone therapy: Insights from inflammation and hemostasis.
    Koh KK; Yoon BK
    Cardiovasc Res; 2006 Apr; 70(1):22-30. PubMed ID: 16412400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk.
    Lobo RA
    Maturitas; 2005 May; 51(1):98-109. PubMed ID: 15883114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Postmenopausal hormone replacement and cardiovascular disease].
    Oian P; Aune B
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):193-6. PubMed ID: 8430399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic effects of hormone replacement therapy.
    Stevenson JC
    J Br Menopause Soc; 2004 Dec; 10(4):157-61. PubMed ID: 15667752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postmenopausal estrogen and cardiovascular disease.
    Stampfer MJ; Grodstein F; Bechtel S
    Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Climacteric; 2007 Dec; 10(6):508-26. PubMed ID: 18049944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
    Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
    Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aging, menopause, and free radicals.
    Schwenke DC
    Semin Reprod Endocrinol; 1998; 16(4):281-308. PubMed ID: 10101810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Menopause. Hormone substitution therapy and prevention of cardiovascular risk].
    Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R
    Minerva Ginecol; 1998; 50(7-8):329-31. PubMed ID: 9808958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.
    Gungor F; Kalelioglu I; Turfanda A
    Angiology; 2009; 60(3):308-17. PubMed ID: 18505742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women.
    Wagner JD; Clarkson TB
    Semin Reprod Med; 2005 May; 23(2):149-56. PubMed ID: 15852200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular disease and ovarian function.
    Kallen AN; Pal L
    Curr Opin Obstet Gynecol; 2011 Aug; 23(4):258-67. PubMed ID: 21681091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HRT and heart disease: problems and prospects.
    Maas AH; van der Graaf Y; van der Schouw YT; Grobbee DE
    Maturitas; 2004 Apr; 47(4):255-8. PubMed ID: 15063476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
    Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
    Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hormone replacement therapy and cardiovascular prevention. Where are we now?].
    Lerman J; Siseles N
    Medicina (B Aires); 2008; 68(3):251-7. PubMed ID: 18689159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular disease, menopause, and the influence of hormone replacement therapy.
    Lobo RA
    Prog Clin Biol Res; 1989; 320():313-32. PubMed ID: 2690141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.